PUBLICATION

Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response

Authors
Germeys, C., Vandoorne, T., Davie, K., Poovathingal, S., Heeren, K., Vermeire, W., Nami, F., Moisse, M., Quaegebeur, A., Sierksma, A., Rué, L., Sicart, A., Eykens, C., De Cock, L., De Strooper, B., Carmeliet, P., Van Damme, P., De Bock, K., Van Den Bosch, L.
ID
ZDB-PUB-240911-7
Date
2024
Source
Cell Reports   43: 114719114719 (Journal)
Registered Authors
Keywords
ALS, C9orf72, CP: Neuroscience, EGLN2, PHD1, SOD1, astrocyte, cGAS/STING, interferon, motor neuron, single-nucleus RNA sequencing
MeSH Terms
  • Hypoxia-Inducible Factor-Proline Dioxygenases/antagonists & inhibitors
  • Hypoxia-Inducible Factor-Proline Dioxygenases/genetics
  • Hypoxia-Inducible Factor-Proline Dioxygenases/metabolism
  • Zebrafish*/metabolism
  • Mice
  • Astrocytes*/metabolism
  • Amyotrophic Lateral Sclerosis*/drug therapy
  • Amyotrophic Lateral Sclerosis*/genetics
  • Amyotrophic Lateral Sclerosis*/metabolism
  • Amyotrophic Lateral Sclerosis*/pathology
  • Humans
  • Animals
  • Interferons/metabolism
  • Disease Models, Animal
  • Induced Pluripotent Stem Cells/metabolism
  • Motor Neurons*/metabolism
(all 16)
PubMed
39255062 Full text @ Cell Rep.
Abstract
Neuroinflammation and dysregulated energy metabolism are linked to motor neuron degeneration in amyotrophic lateral sclerosis (ALS). The egl-9 family hypoxia-inducible factor (EGLN) enzymes, also known as prolyl hydroxylase domain (PHD) enzymes, are metabolic sensors regulating cellular inflammation and metabolism. Using an oligonucleotide-based and a genetic approach, we showed that the downregulation of Egln2 protected motor neurons and mitigated the ALS phenotype in two zebrafish models and a mouse model of ALS. Single-nucleus RNA sequencing of the murine spinal cord revealed that the loss of EGLN2 induced an astrocyte-specific downregulation of interferon-stimulated genes, mediated via the stimulator of interferon genes (STING) protein. In addition, we found that the genetic deletion of EGLN2 restored this interferon response in patient induced pluripotent stem cell (iPSC)-derived astrocytes, confirming the link between EGLN2 and astrocytic interferon signaling. In conclusion, we identified EGLN2 as a motor neuron protective target normalizing the astrocytic interferon-dependent inflammatory axis in vivo, as well as in patient-derived cells.
Genes / Markers
Figures
Figure Gallery (6 images)
Show all Figures
Expression
No data available
Phenotype
No data available
Mutations / Transgenics
No data available
Human Disease / Model
No data available
Sequence Targeting Reagents
Target Reagent Reagent Type
egln2MO1-egln2MRPHLNO
1 - 1 of 1
Show
Fish
No data available
Antibodies
No data available
Orthology
No data available
Engineered Foreign Genes
No data available
Mapping
No data available
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Citation
Germeys, C., Vandoorne, T., Davie, K., Poovathingal, S., Heeren, K., Vermeire, W., Nami, F., Moisse, M., Quaegebeur, A., Sierksma, A., Rué, L., Sicart, A., Eykens, C., De Cock, L., De Strooper, B., Carmeliet, P., Van Damme, P., De Bock, K., Van Den Bosch, L. (2024) Targeting EGLN2/PHD1 protects motor neurons and normalizes the astrocytic interferon response. Cell Reports. 43:114719114719.